Algert Global’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-44,716
Closed -$3.58M 1297
2026
Q1
$3.58M Sell
44,716
-7,661
-15% -$632K 0.05% 540
2025
Q4
$4.47M Sell
52,377
-587
-1% -$48.2K 0.07% 482
2025
Q3
$4.12M Buy
52,964
+47,334
+841% +$3.7M 0.07% 463
2025
Q2
$440K Buy
+5,630
New +$420K 0.01% 959
2025
Q1
Sell
-11,812
Closed -$874K 1222
2024
Q4
$874K Sell
11,812
-52,313
-82% -$3.66M 0.02% 813
2024
Q3
$4.23M Buy
64,125
+59,509
+1,289% +$4.32M 0.11% 312
2024
Q2
$426K Buy
4,616
+1,280
+38% +$113K 0.01% 972
2024
Q1
$319K Sell
3,336
-4,252
-56% -$357K 0.01% 876
2023
Q4
$579K Buy
7,588
+959
+14% +$66.7K 0.02% 777
2023
Q3
$459K Sell
6,629
-11,456
-63% -$921K 0.02% 769
2023
Q2
$1.71M Hold
18,085
0.07% 448
2023
Q1
$1.5M Buy
18,085
+5,270
+41% +$414K 0.07% 456
2022
Q4
$956K Buy
12,815
+8,137
+174% +$627K 0.05% 590
2022
Q3
$387K Buy
4,678
+79
+2% +$7.6K 0.02% 879
2022
Q2
$437K Buy
+4,599
New +$476K 0.03% 803
2022
Q1
Sell
-6,040
Closed -$782K 1212
2021
Q4
$782K Sell
6,040
-8,021
-57% -$936K 0.1% 355
2021
Q3
$1.59M Buy
+14,061
New +$1.6M 0.21% 95

Other funds holding EW

Algert Global's EW Position: Q2 2026 in Review

Algert Global sold out of Edwards Lifesciences (EW) in Q2 2026, closing a stake of 44,716 shares — an estimated $3.58M sold.

Algert Global first reported a position in EW in Q3 2021 and held it in 17 quarters. The position peaked at $4.47M in Q4 2025. 1,325 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Algert Global reported no remaining Edwards Lifesciences position as of Q2 2026 after selling out during the quarter.
  • Algert Global sold 44,716 Edwards Lifesciences shares in Q2 2026, an estimated $3.58M.
  • Algert Global first reported a position in Edwards Lifesciences in Q3 2021 and held it in 17 quarters.
  • Algert Global's Edwards Lifesciences position peaked at $4.47M in Q4 2025.
  • 1,325 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Algert Global's 13F filing for Q2 2026, filed 13 Aug 2026.